Globe Newswire WEST LAFAYETTE, Ind., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and...\n more…
Simply Wall St Inotiv ( NASDAQ:NOTV ) Third Quarter 2024 Results Key Financial Results Revenue: US$105.8m (down 33% from 3Q 2023). Net...\n more…
Ticker Report Inotiv (NASDAQ:NOTV - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.09) by ($0.11...\n more…
Zolmax Inotiv (NASDAQ:NOTV - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of...\n more…
Zacks Investment Research Inotiv, Inc. (NOTV) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to earnings of $0.07 per share a year ago. These figures...\n more…